» Articles » PMID: 36918566

Regional Clozapine, ECT and Lithium Usage Inversely Associated with Excess Suicide Rates in Male Adolescents

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Mar 15
PMID 36918566
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced psychiatric treatments remain uncertain in preventing suicide among adolescents. Across the 21 Swedish regions, using nationwide registers between 2016-2020, we found negative correlation between adolescent excess suicide mortality (AESM) and regional frequencies of clozapine, ECT, and lithium (CEL) usage among adolescents (β = -0.613, p = 0.0003, 95% CI: -0.338, -0.889) and males (β = -0.404, p = 0.009, 95% CI: -0.130, -0.678). No correlation was found among females (p = 0.197). Highest CEL usage among male adolescents was seen in regions with lowest quartile (Q1) AESM (W = 74, p = 0.012). Regional CEL treatment frequency in 15-19-year-olds was related to lower AESM in males, reflecting potential treatment efficacy, treatment compliance or better-quality mental health care. Suicide prevention may benefit from early recognition and CEL treatment for severe mental illness in male adolescents. The results indicate association but further research, using independent samples and both prospective and observational methodologies, is needed to confirm causality.

Citing Articles

Scoping review on prevention of suicidal thoughts and behaviors in adolescents: methods, effectiveness and future directions.

Aoun J, Spodenkiewicz M, Marimoutou C Front Child Adolesc Psychiatry. 2025; 3:1367075.

PMID: 39839316 PMC: 11748894. DOI: 10.3389/frcha.2024.1367075.


Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data.

De Las Cuevas C, Sanz E, Jimenez-Fernandez S, Schoretsanitis G, Ruan C, De Leon J Eur Child Adolesc Psychiatry. 2024; .

PMID: 39621136 DOI: 10.1007/s00787-024-02623-3.


Efficacy and Safety of Lithium for Suicide and Suicide-Related Behaviors in Youth: A Review of the Literature.

Sesso G, Bargnesi F, Olzi F, Mutti G, Berloffa S, Viglione V Brain Sci. 2024; 14(11).

PMID: 39595902 PMC: 11592384. DOI: 10.3390/brainsci14111139.


Extended-Release Lithium Treatment for Adolescents with Bipolar Disorder with or Without Comorbid Autism Spectrum Disorder: Protocol of a Longitudinal Prospective Naturalistic Study for the Assessment of Efficacy and Tolerability.

Sesso G, Bargnesi F, Mutti G, Berloffa S, Viglione V, Fantozzi P J Clin Med. 2024; 13(20).

PMID: 39458145 PMC: 11508904. DOI: 10.3390/jcm13206196.


Prevention of suicidal behavior with lithium treatment in patients with recurrent mood disorders.

Tondo L, Baldessarini R Int J Bipolar Disord. 2024; 12(1):6.

PMID: 38460088 PMC: 10924823. DOI: 10.1186/s40345-024-00326-x.


References
1.
Fazel S, Runeson B . Suicide. N Engl J Med. 2020; 382(3):266-274. PMC: 7116087. DOI: 10.1056/NEJMra1902944. View

2.
Brent D . Master Clinician Review: Saving Holden Caulfield: Suicide Prevention in Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2018; 58(1):25-35. DOI: 10.1016/j.jaac.2018.05.030. View

3.
Gorelick D, Vyas G . Suicide. N Engl J Med. 2020; 382(21):e66. DOI: 10.1056/NEJMc2002190. View

4.
Ghaziuddin N, Shamseddeen W, Gettys G, Ghaziuddin M . Electroconvulsive Therapy for the Treatment of Severe Mood Disorders During Adolescence: A Retrospective Chart Review. J Child Adolesc Psychopharmacol. 2020; 30(4):235-243. DOI: 10.1089/cap.2019.0054. View

5.
Wasserman D, Hoven C, Wasserman C, Wall M, Eisenberg R, Hadlaczky G . School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial. Lancet. 2015; 385(9977):1536-44. DOI: 10.1016/S0140-6736(14)61213-7. View